FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137178489> ?p ?o ?g. }

• W3137178489 endingPage "496" @default.
• W3137178489 startingPage "488" @default.
• W3137178489 abstract "BACKGROUND: The value assessment framework (VAF) is one approach to assessing the evidence and value of medications. VAFs are a way to measure and communicate the value of medications and other health care technologies for decision-making purposes. Given the increasing number of high-cost medications, challenging formulary inquiries, and critiques of currently available tools, health systems need to explore a standardized way to incorporate value assessment into formulary decision making. OBJECTIVES: To (a) evaluate existing VAFs by measuring inter-rater reliability among typical clinicians completing formulary reviews and (b) explore general implications of applying these tools to formulary decision making for all medications at a large academic health system. METHODS: This was a retrospective, observational study at a single health system. A list of medications added, denied, and removed from the system formulary from September 1, 2013, through August 31, 2018, was collected. Published VAFs, such as the American Society of Clinical Oncology (ASCO) Value Framework, European Society of Medical Oncology (ESMO) Magnitude of Clinical Benefit Scale, National Comprehensive Cancer Network (NCCN) Evidence Blocks, American College of Cardiology/American Heart Association Value Framework, and the incremental cost-effectiveness ratio (ICER) calculation were applied by 3 different reviewer groups. The primary outcome was inter-rater reliability among the 3 different reviewers for a given framework. Cohen's weighted kappa and the intraclass correlation coefficient (ICC) were used to assess inter-rater reliability. RESULTS: The frameworks were applied to 94 medications. The VAFs with the highest ICCs between all 3 raters were NCCN (0.635; 95% CI = 0.387-0.823) and ASCO (0.634; 95% CI = 0.370-0.832), both indicating moderate inter-rater reliability. The VAFs with the lowest ICCs were ESMO (0.368; 95% CI = 0.126-0.611) and ICER (0.159; 95% = CI -0.018-0.365), with ICCs corresponding to poor reliability. CONCLUSIONS: Because high-cost medications are a challenge to health systems, VAFs may be beneficial to target formulary decision making in this setting. Applying VAFs proactively may improve interrater reliability and usability in formulary decision making. DISCLOSURES: No outside funding supported this study. The authors have nothing to disclose." @default.
• W3137178489 created "2021-03-29" @default.
• W3137178489 creator A5006061800 @default.
• W3137178489 creator A5025998325 @default.
• W3137178489 creator A5079335285 @default.
• W3137178489 creator A5081597757 @default.
• W3137178489 date "2021-04-01" @default.
• W3137178489 modified "2023-09-23" @default.
• W3137178489 title "Verifying the value of existing frameworks for formulary review at a large academic health system: assessing inter-rater reliability" @default.
• W3137178489 cites W2010913334 @default.
• W3137178489 cites W2050056063 @default.
• W3137178489 cites W2063085086 @default.
• W3137178489 cites W2070952612 @default.
• W3137178489 cites W2072727975 @default.
• W3137178489 cites W2117419474 @default.
• W3137178489 cites W2134119471 @default.
• W3137178489 cites W2145471207 @default.
• W3137178489 cites W2312549738 @default.
• W3137178489 cites W2327037637 @default.
• W3137178489 cites W2402609319 @default.
• W3137178489 cites W2412558745 @default.
• W3137178489 cites W2413636075 @default.
• W3137178489 cites W2513403311 @default.
• W3137178489 cites W2582604900 @default.
• W3137178489 cites W2587262192 @default.
• W3137178489 cites W2590456758 @default.
• W3137178489 cites W2612359321 @default.
• W3137178489 cites W2619351549 @default.
• W3137178489 cites W2621024184 @default.
• W3137178489 cites W2787881284 @default.
• W3137178489 cites W2788999563 @default.
• W3137178489 cites W2795887957 @default.
• W3137178489 cites W2903430584 @default.
• W3137178489 cites W2904351017 @default.
• W3137178489 cites W2916984615 @default.
• W3137178489 cites W2965165229 @default.
• W3137178489 cites W2982378757 @default.
• W3137178489 cites W3201540941 @default.
• W3137178489 doi "https://doi.org/10.18553/jmcp.2021.27.4.488" @default.
• W3137178489 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33769852" @default.
• W3137178489 hasPublicationYear "2021" @default.
• W3137178489 type Work @default.
• W3137178489 sameAs 3137178489 @default.
• W3137178489 citedByCount "0" @default.
• W3137178489 crossrefType "journal-article" @default.
• W3137178489 hasAuthorship W3137178489A5006061800 @default.
• W3137178489 hasAuthorship W3137178489A5025998325 @default.
• W3137178489 hasAuthorship W3137178489A5079335285 @default.
• W3137178489 hasAuthorship W3137178489A5081597757 @default.
• W3137178489 hasBestOaLocation W31371784891 @default.
• W3137178489 hasConcept C100406419 @default.
• W3137178489 hasConcept C104709138 @default.
• W3137178489 hasConcept C121332964 @default.
• W3137178489 hasConcept C126322002 @default.
• W3137178489 hasConcept C138496976 @default.
• W3137178489 hasConcept C15744967 @default.
• W3137178489 hasConcept C160735492 @default.
• W3137178489 hasConcept C162324750 @default.
• W3137178489 hasConcept C163258240 @default.
• W3137178489 hasConcept C171606756 @default.
• W3137178489 hasConcept C19527891 @default.
• W3137178489 hasConcept C23131810 @default.
• W3137178489 hasConcept C43214815 @default.
• W3137178489 hasConcept C50522688 @default.
• W3137178489 hasConcept C512399662 @default.
• W3137178489 hasConcept C61863361 @default.
• W3137178489 hasConcept C62520636 @default.
• W3137178489 hasConcept C70410870 @default.
• W3137178489 hasConcept C71924100 @default.
• W3137178489 hasConcept C83849319 @default.
• W3137178489 hasConceptScore W3137178489C100406419 @default.
• W3137178489 hasConceptScore W3137178489C104709138 @default.
• W3137178489 hasConceptScore W3137178489C121332964 @default.
• W3137178489 hasConceptScore W3137178489C126322002 @default.
• W3137178489 hasConceptScore W3137178489C138496976 @default.
• W3137178489 hasConceptScore W3137178489C15744967 @default.
• W3137178489 hasConceptScore W3137178489C160735492 @default.
• W3137178489 hasConceptScore W3137178489C162324750 @default.
• W3137178489 hasConceptScore W3137178489C163258240 @default.
• W3137178489 hasConceptScore W3137178489C171606756 @default.
• W3137178489 hasConceptScore W3137178489C19527891 @default.
• W3137178489 hasConceptScore W3137178489C23131810 @default.
• W3137178489 hasConceptScore W3137178489C43214815 @default.
• W3137178489 hasConceptScore W3137178489C50522688 @default.
• W3137178489 hasConceptScore W3137178489C512399662 @default.
• W3137178489 hasConceptScore W3137178489C61863361 @default.
• W3137178489 hasConceptScore W3137178489C62520636 @default.
• W3137178489 hasConceptScore W3137178489C70410870 @default.
• W3137178489 hasConceptScore W3137178489C71924100 @default.
• W3137178489 hasConceptScore W3137178489C83849319 @default.
• W3137178489 hasIssue "4" @default.
• W3137178489 hasLocation W31371784891 @default.
• W3137178489 hasLocation W31371784892 @default.
• W3137178489 hasOpenAccess W3137178489 @default.
• W3137178489 hasPrimaryLocation W31371784891 @default.
• W3137178489 hasRelatedWork W1967396427 @default.
• W3137178489 hasRelatedWork W1993050967 @default.
• W3137178489 hasRelatedWork W2015957719 @default.

• next